Literature DB >> 16423266

Surfactant catabolism.

Machiko Ikegami1.   

Abstract

Alveolar pulmonary surfactant is a complex of macromolecular aggregates composed of phospholipids and surfactant proteins (SP) that is essential for maintenance of normal lung function. The importance of surfactant homeostasis is recognized in the patients and the animal models with pulmonary disease, although the mechanisms of surfactant homeostasis are not fully understood. In this review the author will discuss: (i) the mechanisms of the surfactant catabolism by macrophage and type II cells; and (ii) the important role of SP-D on ultrastructure of surfactant that affects uptake by type II cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16423266     DOI: 10.1111/j.1440-1843.2006.00803.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  7 in total

Review 1.  Surfactant phospholipid metabolism.

Authors:  Marianna Agassandian; Rama K Mallampalli
Journal:  Biochim Biophys Acta       Date:  2012-09-29

2.  Epithelial Gpr116 regulates pulmonary alveolar homeostasis via Gq/11 signaling.

Authors:  Kari Brown; Alyssa Filuta; Marie-Gabrielle Ludwig; Klaus Seuwen; Julian Jaros; Solange Vidal; Kavisha Arora; Anjaparavanda P Naren; Kathirvel Kandasamy; Kaushik Parthasarathi; Stefan Offermanns; Robert J Mason; William E Miller; Jeffrey A Whitsett; James P Bridges
Journal:  JCI Insight       Date:  2017-06-02

3.  Orphan G protein-coupled receptor GPR116 regulates pulmonary surfactant pool size.

Authors:  James P Bridges; Marie-Gabrielle Ludwig; Matthias Mueller; Bernd Kinzel; Atsuyasu Sato; Yan Xu; Jeffrey A Whitsett; Machiko Ikegami
Journal:  Am J Respir Cell Mol Biol       Date:  2013-09       Impact factor: 6.914

4.  Modeling pulmonary alveolar microlithiasis by epithelial deletion of the Npt2b sodium phosphate cotransporter reveals putative biomarkers and strategies for treatment.

Authors:  Atsushi Saito; Nikolaos M Nikolaidis; Hassane Amlal; Yasuaki Uehara; Jason C Gardner; Kathleen LaSance; Lori B Pitstick; James P Bridges; Kathryn A Wikenheiser-Brokamp; Dennis W McGraw; Jason C Woods; Yves Sabbagh; Susan C Schiavi; Göksel Altinişik; Marko Jakopović; Yoshikazu Inoue; Francis X McCormack
Journal:  Sci Transl Med       Date:  2015-11-11       Impact factor: 17.956

5.  In vivo effect of pneumonia on surfactant disaturated-phosphatidylcholine kinetics in newborn infants.

Authors:  Maddalena Facco; Matteo Nespeca; Manuela Simonato; Ilena Isak; Giovanna Verlato; Gianluca Ciambra; Chiara Giorgetti; Virgilio P Carnielli; Paola E Cogo
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

6.  The effect of titanium dioxide nanoparticles on pulmonary surfactant function and ultrastructure.

Authors:  Carsten Schleh; Christian Mühlfeld; Karin Pulskamp; Andreas Schmiedl; Matthias Nassimi; Hans D Lauenstein; Armin Braun; Norbert Krug; Veit J Erpenbeck; Jens M Hohlfeld
Journal:  Respir Res       Date:  2009-09-30

7.  Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy.

Authors:  Abul Bashar Mir Md Khademul Islam; Md Abdullah-Al-Kamran Khan
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.